bergenin has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Lin, H; Shan, L; Wang, P; Xie, M; Yan, H; Yan, L; Yu, H; Zhang, W | 1 |
| Du, G; Lv, Y; Wang, J; Wang, L; Wang, X; Yang, S; Yu, Z; Yuan, T; Zhang, X | 1 |
2 other study(ies) available for bergenin and Lung Injury, Acute
| Article | Year |
|---|---|
Novel Combined Preparation and Investigation of Bergenin-Loaded Albumin Nanoparticles for the Treatment of Acute Lung Injury: In Vitro and In Vivo Evaluations.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Benzopyrans; Drug Compounding; Drug Delivery Systems; Female; Humans; In Vitro Techniques; Male; Mice; Nanoparticles; Rats; Rats, Wistar; Serum Albumin, Bovine; Treatment Outcome | 2022 |
The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Topics: Acute Lung Injury; Animals; Benzopyrans; Biological Products; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Random Allocation | 2017 |